JNJ-63623872/Oseltamivir fixed-dose combination tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-63623872/Oseltamivir fixed-dose combination tablet, covering 2017-05-25 to 2017-05-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult Participants [Phase 1]